Sumitomo Pharma Co Ltd DNPUF
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- $2.99
- Day Range
- $3.19–3.19
- 52-Week Range
- $2.83–7.60
- Bid/Ask
- $3.06 / $3.35
- Market Cap
- $1.27 Bil
- Volume/Avg
- 15,600 / 4,502
Key Statistics
- Price/Earnings (Normalized)
- 4.31
- Price/Sales
- 0.45
- Dividend Yield
- 1.52%
- Dividend Yield (Forward)
- 0.02%
- Total Yield
- 1.52%
Company Profile
Sumitomo Pharma Co Ltd is a specialty and generic drug manufacturing company. Sumitomo's vast majority of sales are generated in North America, followed by Japan. The company's core business is its pharmaceutical products business. The pharmaceutical business maintains a focus on a variety of areas, including cardiovascular/diabetes, psychiatry & neurology, and specialty areas. Sumitomo considers merger and acquisition investment as a potential component of its operational growth strategy for expanding its research, development, manufacturing, and marketing capabilities.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Stock Style Box
- Mid Value
- Total Number of Employees
- 6,250
- Website
- https://www.sumitomo-pharma.com
Valuation
|
Metric
|
DNPUF
|
|---|---|
Price/Earnings (Normalized) | 4.31 |
Price/Book Value | 0.46 |
Price/Sales | 0.45 |
Price/Cash Flow | — |
Price/Earnings
DNPUF
Financial Strength
|
Metric
|
DNPUF
|
|---|---|
Quick Ratio | 0.45 |
Current Ratio | 0.79 |
Interest Coverage | −4.19 |
Quick Ratio
DNPUF
Profitability
|
Metric
|
DNPUF
|
|---|---|
Return on Assets (Normalized) | −9.94% |
Return on Equity (Normalized) | −24.49% |
Return on Invested Capital (Normalized) | −15.39% |
Return on Assets
DNPUF
Drug Manufacturers - Specialty & Generic Industry Comparables
|
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|
ZTS
| Zoetis Inc Class A | Bfwqv | $82.2 Bil | |
MKKGY
| Merck KGaA ADR | Dylnm | $75.8 Bil | |
HLN
| Haleon PLC ADR | Vncg | $38.8 Bil | |
RDY
| Dr Reddy's Laboratories Ltd ADR | Gcfny | $11.5 Bil | |
VTRS
| Viatris Inc | Xlg | $11.2 Bil | |
CTLT
| Catalent Inc | Pvxkwk | $7.2 Bil | |
PRGO
| Perrigo Co PLC | Jkkh | $4.2 Bil | |
PBH
| Prestige Consumer Healthcare Inc | Thtqxgl | $2.9 Bil | |
CURLF
| Curaleaf Holdings Inc | Cdtz | $2.6 Bil | |
GTBIF
| Green Thumb Industries Inc | Phj | $2.5 Bil |